Cited by 1,039Inflammasome and immune disordersAtherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

Open access

Rajamäki, Kristiina, Lappalainen, Jani, Öörni, Katariina, Välimäki, Elina, Matikainen, Sampsa, Kovanen, Petri T., Eklund, Kari K.·2010·PLoS ONE

DOI 10.1371/journal.pone.0011765PMC PMC2909263

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Chronic inflammation of the arterial wall is a key element in the pathogenesis of atherosclerosis, yet the factors that trigger and sustain the inflammation remain elusive. Inflammasomes are cytoplasmic caspase-1-activating protein complexes that promote maturation and secretion of the proinflammatory cytokines interleukin(IL)-1beta and IL-18. The most intensively studied inflammasome, NLRP3 inflammasome, is activated by diverse substances, including crystalline and particulate materials. As cholesterol crystals are abundant in atherosclerotic lesions, and IL-1beta has been linked to atherogenesis, we explored the possibility that cholesterol crystals promote inflammation by activating the inflammasome pathway. PRINCIPAL FINDINGS: Here we show that human macrophages avidly phagocytose cholesterol crystals and store the ingested cholesterol as cholesteryl esters. Importantly, cholesterol crystals induced dose-dependent secretion of mature IL-1beta from human monocytes and macrophages. The cholesterol crystal-induced secretion of IL-1beta was caspase-1-dependent, suggesting the involvement of an inflammasome-mediated pathway. Silencing of the NLRP3 receptor, the crucial component in NLRP3 inflammasome, completely abolished crystal-induced IL-1beta secretion, thus identifying NLRP3 inflammasome as the cholesterol crystal-responsive element in macrophages. The crystals were shown to induce leakage of the lysosomal protease cathepsin B into the cytoplasm and inhibition of this enzyme reduced cholesterol crystal-induced IL-1beta secretion, suggesting that NLRP3 inflammasome activation occurred via lysosomal destabilization. CONCLUSIONS: The cholesterol crystal-induced inflammasome activation in macrophages may represent an important link between cholesterol metabolism and inflammation in atherosclerotic lesions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0011765

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 1×
“While this study was being finalized, Duewell and colleagues published a similar study reporting that cholesterol crystals activate the NLRP3 inflammasome in mouse macrophages through a lysosomal damage- and cathepsin-mediated mechanism”
Background
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature reviews. Immunology · doi:10.1038/nri2725 · Cited by 1,859
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,751

Flagged first, then by citations

Show all 60 references

2 of the 60 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 998

Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis
Sergin, I., Bhattacharya, S., Emanuel, R., Esen, E., Stokes, C. J., Evans, T. D., Arif, B., Curci, J. A., & Razani, B. (2016) · Science Signaling · doi:10.1126/scisignal.aad5614 · Cited by 108
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
Robinson, J. G., Williams, K. J., Gidding, S. S., Borén, J., Tabas, I. A., Fisher, E. A. A., Packard, C. J., Pencina, M. J., Fayad, Z. A., Mani, V., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009778 · Cited by 109
Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy
Peng, S., Xu, L., Che, X., Xiao, Q., Pu, J., Shao, Q., & He, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00438 · Cited by 107
Regulating metabolic inflammation by nutritional modulation
Charles‐Messance, H., Mitchelson, K. A. J., Castro, E. D. M., Sheedy, F. J., & Roche, H. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.013 · Cited by 121
P2X 7 Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice
Stachon, P., Heidenreich, A., Merz, J., Hilgendorf, I., Wolf, D., Willecke, F., von Garlen, S., Albrecht, P., Härdtner, C., Ehrat, N., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027400 · Cited by 106
The lipid basis of cell death and autophagy
Lin, Z., Long, F., Kang, R., Klionsky, D. J., Yang, M., & Tang, D. (2023) · Autophagy · doi:10.1080/15548627.2023.2259732 · Cited by 107
Macrophages and Intravascular OCT Bright Spots
Phipps, J. E., Vela, D. C., Hoyt, T., Halaney, D. L., Mancuso, J. J., Buja, L. M., Asmis, R., Milner, T. E., & Feldman, M. D. (2014) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.07.027 · Cited by 103
Lipids, inflammasomes, metabolism, and disease
Anand, P. (2020) · Immunological Reviews · doi:10.1111/imr.12891 · Cited by 108
Danger Signaling in Atherosclerosis
Zimmer, S., Grebe, A., & Latz, E. (2015) · Circulation Research · doi:10.1161/circresaha.116.301135 · Cited by 106
Immunometabolic rewiring of tubular epithelial cells in kidney disease
van der Rijt, S., Leemans, J. C., Florquin, S., Houtkooper, R. H., & Tammaro, A. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00592-x · Cited by 105
Regulated Necrosis in Atherosclerosis
Puylaert, P., Zurek, M., Rayner, K. J., Meyer, G. R. Y. D., & Martinet, W. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318177 · Cited by 111
Acidification of the intimal fluid: the perfect storm for atherogenesis
Öörni, K., Rajamäki, K., Nguyen, S. D., Lähdesmäki, K., Plihtari, R., Lee-Rueckert, M., & Kovanen, P. T. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r050252 · Cited by 101
Self-citation
The autoimmune concept of atherosclerosis
Grundtman, C., & Wick, G. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834aa0c2 · Cited by 102
Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia
Koka, S., Xia, M., Chen, Y., Bhat, O. M., Yuan, X., Boini, K. M., & Li, P. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.004 · Cited by 101
Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3
Ye, J., Li, L., Wang, M., Ma, Q., Tian, Y., Zhang, Q., Liu, J., Li, B., Zhang, B., Liu, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900254 · Cited by 110
Apolipoprotein B-containing lipoproteins in atherogenesis
Borén, J., Packard, C. J., & Binder, C. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01111-0 · Cited by 110
Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
Shapiro, M. D., & Fazio, S. (2017) · F1000Research · doi:10.12688/f1000research.9845.1 · Cited by 103
Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation
de la Roche, M., Hamilton, C., Mortensen, R., Jeyaprakash, A. A., Ghosh, S., & Anand, P. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201709057 · Cited by 102
Metabolism-Associated Molecular Patterns (MAMPs)
Wang, X., Wang, Y., Antony, V., Sun, H., & Liang, G. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.07.001 · Cited by 95
Silent Monosodium Urate Crystal Deposits Are Associated With Severe Coronary Calcification in Asymptomatic Hyperuricemia: An Exploratory Study
Andrés, M., Quintanilla, M. A., Sivera, F., Sánchez–Payá, J., Pascual, E., Vela, P., & Ruiz-Nodar, J. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39581 · Cited by 96
Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy
Shen, L., Yang, Y., Ou, T., Key, C.-C. C., Tong, S. H., Sequeira, R. C., Nelson, J. M., Nie, Y., Wang, Z., Boudyguina, E. Y., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075879 · Cited by 98
Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
Altaf, A., Qu, P., Zhao, Y., Kuang, P., Wang, H., Lou, D., Niu, N., & Yuan, D. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0723-8 · Cited by 95
Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH
Ioannou, G. N., Rooyen, D. M. V., Savard, C. E., Haigh, W. G., Yeh, M. M., Teoh, N., & Farrell, G. C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m053785 · Cited by 95
Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases
Escarcega, R. O., Lipinski, M. J., García‐Carrasco, M., Pinto, C. M., Gálvez-Romero, J. L., & Cervera, R. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.021 · Cited by 93
Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
Liberale, L., Ministrini, S., Carbone, F., Camici, G. G., & Montecucco, F. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00863-x · Cited by 93
New Roles of HDL in Inflammation and Hematopoiesis
Zhu, X., & Parks, J. S. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150709 · Cited by 94
Oxidative Stress and Inflammation Induced by Environmental and Psychological Stressors: A Biomarker Perspective
Ghezzi, P., Floridi, L., Boraschi, D., Cuadrado, A., Manda, G., Levic, S., D’Acquisto, F., Hamilton, A., Athersuch, T. J., & Selley, L. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7147 · Cited by 95
Coronary Endothelial Dysfunction Induced by Nucleotide Oligomerization Domain-Like Receptor Protein with Pyrin Domain Containing 3 Inflammasome Activation During Hypercholesterolemia: Beyond Inflammation
Zhang, Y., Li, X., Pitzer, A. L., Chen, Y., Wang, L., & Li, P. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5978 · Cited by 90
Consolidated and emerging inflammatory markers in coronary artery disease
Lubrano, V. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i1.21 · Cited by 92
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities
Galozzi, P., Bindoli, S., Doria, A., & Sfriso, P. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102785 · Cited by 91
Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells
Corrêa, R., Silva, L. F. F., Ribeiro, D. J. S., Almeida, R. D. N., Santos, I. D. O., Corrêa, L. H., de Sant’Ana, L. P., Assunção, L. S., Bozza, P. T., & Magalhães, K. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02927 · Cited by 93
NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19
López-Reyes, A. G., Martínez-Armenta, C., Espinosa-Velázquez, R., Vázquez-Cárdenas, P., Cruz‐Ramos, M., Palacios‐González, B., Gómez-Quiroz, L. E., & Martínez‐Nava, G. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570251 · Cited by 95
Overcoming Preclinical Safety Obstacles to Discover (S)-N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 Inhibitor
McBride, C., Trzoss, L., Povero, D., Lazić, M., Ambrus-Aikelin, G., Santini, A. M., Pranadinata, R. F., Bain, G., Stansfield, R. K., Stafford, J. A., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01250 · Cited by 95
Apoptosis-Associated Speck–like Protein Containing a Caspase Recruitment Domain Inflammasomes Mediate IL-1β Response and Host Resistance to Trypanosoma cruzi Infection
Silva, G. K., Sesti‐Costa, R., Silveira, T. N., Caetano, B. C., Horta, C. V., Gutierrez, F. R. S., Guedes, P. M. D. M., Andrade, W. A., Niz, M. D., Gazzinelli, R. T., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203293 · Cited by 89
The fat cell senescence hypothesis
Newsholme, P., & de Bittencourt, P. I. H. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000077 · Cited by 92
p38γ and p38δ: From Spectators to Key Physiological Players
Cuenda, A., & Sanz‐Ezquerro, J. J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.02.008 · Cited by 90
Cellular and molecular mechanisms of statins: an update on pleiotropic effects
Satoh, M., Takahashi, Y., Tabuchi, T., Minami, Y., Tamada, M., Takahashi, K., Itoh, T., Morino, Y., & Nakamura, M. (2015) · Clinical Science · doi:10.1042/cs20150027 · Cited by 92
Activation of the NLRP3 inflammasome by cellular labile iron
Nakamura, K., Kawakami, T., Yamamoto, N., Tomizawa, M., Fujiwara, T., Ishii, T., Harigae, H., & Ogasawara, K. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.11.002 · Cited by 89
Anti-inflammatory approaches to ischaemic stroke prevention
Kelly, P. J., Murphy, S., Coveney, S. A., Purroy, F. F., Lemmens, R., Tsivgoulis, G. K., & Price, C. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314817 · Cited by 90
The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process
Sebastian-Valverde, M., & Pasinetti, G. M. (2020) · Cells · doi:10.3390/cells9061552 · Cited by 90
Apigenin Alleviated High-Fat-Diet-Induced Hepatic Pyroptosis by Mitophagy-ROS-CTSB-NLRP3 Pathway in Mice and AML12 Cells
Meng, Z., Gao, M., Wang, C., Guan, S., Zhang, D., & Lu, J. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c07581 · Cited by 92
Trapping of oxidized LDL in lysosomes of K upffer cells is a trigger for hepatic inflammation
Bieghs, V., Walenbergh, S. M. A., Hendrikx, T., van Gorp, P. J., Verheyen, F., Damink, S. W. M. O., Masclee, A., Koek, G. H., Hofker, M. H., Binder, C. J., et al. (2013) · Liver International · doi:10.1111/liv.12170 · Cited by 88
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis
Liu, Y., Pan, Y., Yin, Y., Chen, W., & Li, X. (2021) · Virology Journal · doi:10.1186/s12985-021-01604-1 · Cited by 94
Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota
Org, E., Mehrabian, M., & Lusis, A. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.035 · Cited by 85
Moving Beyond JUPITER: Will Inhibiting Inflammation Reduce Vascular Event Rates?
Ridker, P. M. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0295-3 · Cited by 86
NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
Parsamanesh, N., Moossavi, M., Bahrami, A., Fereidouni, M., Barreto, G. E., & Sahebkar, A. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.006 · Cited by 87
Effects of dyslipidaemia on monocyte production and function in cardiovascular disease
Rahman, M. S., Murphy, A. J., & Woollard, K. J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.34 · Cited by 86
Highlighting Residual Atherosclerotic Cardiovascular Disease Risk
Matsuura, Y., Kanter, J. E., & Bornfeldt, K. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311999 · Cited by 88
Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis
Ioannou, G. N., Landis, C. S., Jin, G., Haigh, W. G., Farrell, G. C., Kuver, R., Lee, S. P., & Savard, C. E. (2019) · Hepatology Communications · doi:10.1002/hep4.1348 · Cited by 84
High-density lipoprotein inhibits serum amyloid A–mediated reactive oxygen species generation and NLRP3 inflammasome activation
Shridas, P., de Beer, M. C., & Webb, N. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002428 · Cited by 84
Role of Pyroptosis in Diabetes and Its Therapeutic Implications
Mamun, A. A., Wu, Y., Nasrin, F., Akter, A., Taniya, M. A., Munir, F., Jia, C., & Xiao, J. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s291453 · Cited by 83
Effect of interleukin 1β inhibition in cardiovascular disease
Qamar, A., & Rader, D. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328359b0a6 · Cited by 83
HIV-1 Induces the First Signal to Activate the NLRP3 Inflammasome in Monocyte-Derived Macrophages
Hernández, J. C., Latz, E., & Inchima, S. U. (2013) · Intervirology · doi:10.1159/000353902 · Cited by 79
Extracellular Lipids Accumulate in Human Carotid Arteries as Distinct Three-Dimensional Structures and Have Proinflammatory Properties
Lehti, S., Nguyen, S. D., Belevich, I., Vihinen, H., Heikkilä, H. M., Soliymani, R., Käkelä, R., Saksi, J., Jauhiainen, M., Grabowski, G. A., et al. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.09.019 · Cited by 79
Self-citation
Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability
Nidorf, S. M., Fiolet, A. T. L., & Abela, G. S. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.07.003 · Cited by 79
Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue
Conte, M., Petraglia, L., Poggio, P., Valerio, V., Cabaro, S., Campana, P., Comentale, G., Attena, E., Russo, V., Pilato, E., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.844266 · Cited by 84
Blocking Interleukin-1 as a Novel Therapeutic Strategy for Secondary Prevention of Cardiovascular Events
Abbate, A., Tassell, B. W. V., & Biondi‐Zoccai, G. (2012) · BioDrugs · doi:10.1007/bf03261881 · Cited by 78
Lipid regulation of NLRP3 inflammasome activity through organelle stress
Liang, J. J., Fraser, I. D. C., & Bryant, C. E. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.07.005 · Cited by 79
Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
Lorey, M. B., Öörni, K., & Kovanen, P. T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.841545 · Cited by 82
Self-citation
The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases
Yang, C., Shin, D., & Jo, E. (2012) · International Neurourology Journal · doi:10.5213/inj.2012.16.1.2 · Cited by 81
CRP-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells
Bian, F., Yang, X., Xu, G., Zheng, T., & Jin, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00040 · Cited by 78
Deep Tissue Injury in Development of Pressure Ulcers: A Decrease of Inflammasome Activation and Changes in Human Skin Morphology in Response to Aging and Mechanical Load
Stojadinovic, O., Minkiewicz, J., Sawaya, A., Bourne, J. W., Torzilli, P., de Rivero Vaccari, J. P., Dietrich, W. D., Keane, R. W., & Tomic-Canic, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069223 · Cited by 77
Cyclodextrins: Potential therapeutics against atherosclerosis
Mahjoubin‐Tehran, M., Kovanen, P. T., Xu, S., Jamialahmadi, T., & Sahebkar, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107620 · Cited by 76
Self-citation
NLRP3 Mediates NF-κB Activation and Cytokine Induction in Microbially Induced and Sterile Inflammation
Kinoshita, T., Imamura, R., Kushiyama, H., & Suda, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119179 · Cited by 80
NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins
Altaf, A., Qu, P., Zhao, Y., Wang, H., Lou, D., & Niu, N. (2015) · Coronary Artery Disease · doi:10.1097/mca.0000000000000255 · Cited by 77
Insights into Macrophage Heterogeneity and Cytokine-Induced Neuroinflammation in Major Depressive Disorder
Dey, A., & Hankey Giblin, P. A. (2018) · Pharmaceuticals · doi:10.3390/ph11030064 · Cited by 80
Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease
Jeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101333 · Cited by 76
p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis
Rajamäki, K., Mäyränpää, M. I., Risco, A., Tuimala, J., Nurmi, K., Cuenda, A., Eklund, K. K., Öörni, K., & Kovanen, P. T. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.307312 · Cited by 75
Self-citation
Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non‐alcoholic steatohepatitis
Hendrikx, T., Walenbergh, S. M. A., Hofker, M. H., & Shiri‐Sverdlov, R. (2014) · Obesity Reviews · doi:10.1111/obr.12159 · Cited by 76
The rhapsody of NLRPs: master players of inflammation … and a lot more
Zambetti, L. P., Laudisi, F., Licandro, G., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2012) · Immunologic Research · doi:10.1007/s12026-012-8272-z · Cited by 75
Immunometabolism of AMPK in insulin resistance and atherosclerosis
Fullerton, M. D., Steinberg, G. R., & Schertzer, J. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.004 · Cited by 73
Macrophage Autophagy in Atherosclerosis
Maiuri, M. C., Grassia, G., Platt, A. M., Carnuccio, R., Ialenti, A., & Maffia, P. (2013) · Mediators of Inflammation · doi:10.1155/2013/584715 · Cited by 72
Organic Isothiocyanates as Hydrogen Sulfide Donors
Martelli, A., Citi, V., Testai, L., Brogi, S., & Calderone, V. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7888 · Cited by 74
Colchicine exerts anti‐atherosclerotic and ‑plaque‐stabilizing effects targeting foam cell formation
Schwarz, N., Fernando, S., Chen, Y., Salagaras, T., Rao, S. R., Liyanage, S., Williamson, A. E., Toledo‐Flores, D., Dimasi, C. G., Sargeant, T. J., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201469r · Cited by 81
The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases
Bernardi, S., Marcuzzi, A., Piscianz, E., Tommasini, A., & Fabris, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124058 · Cited by 71
Anti-inflammatory role of GM1 and other gangliosides on microglia
Galleguillos, D., Wang, Q., Steinberg, N., Zaidi, A. K., Shrivastava, G., Dhami, K., Daskhan, G. C., Schmidt, E. N., Dworsky-Fried, Z., Giuliani, F., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02374-x · Cited by 74
Complement C5a potentiates uric acid crystal‐induced IL‐1β production
An, L., Mehta, P., Xu, L., Turman, S., Reimer, T., Naiman, B. M., Connor, J. R., Sanjuán, M. A. F., Kolbeck, R., & Fung, M. S. C. (2014) · European Journal of Immunology · doi:10.1002/eji.201444560 · Cited by 71
NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease
Wang, L., Qu, P., Zhao, J., & Chang, Y. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.44871 · Cited by 71
Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response
Grasset, E. K., Duhlin, A., Agardh, H. E., Овчинникова, О. А., Hägglöf, T., Forsell, M. N. E., Paulsson‐Berne, G., Hansson, G. K., Ketelhuth, D. F. J., & Karlsson, M. C. I. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421227112 · Cited by 71
Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr−/− mice
Hendrikx, T., Jeurissen, M. L. J., van Gorp, P. J., Gijbels, M. J., Walenbergh, S. M. A., Houben, T., van Gorp, R. H., Pöttgens, C. C. H., Stienstra, R., Netea, M. G., et al. (2015) · FEBS Journal · doi:10.1111/febs.13279 · Cited by 73
Sodium sulfite triggered hepatic apoptosis, necroptosis, and pyroptosis by inducing mitochondrial damage in mice and AML-12 cells
Liu, M., Lu, J., Hu, J., Chen, Y., Deng, X., Wang, J., Zhang, S., Guo, J., Li, W., & Guan, S. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133719 · Cited by 70
Regulation of stem cell differentiation in adipose tissue by chronic inflammation
Ye, J., & Gimble, J. M. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05596.x · Cited by 72
First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers
Tang, F., Kunder, R., Chu, T., Hains, A., Nguyen, A., McBride, J. M., Zhong, Y., Santagostino, S., Wilson, M., Trenchak, A., et al. (2023) · Clinical and Translational Science · doi:10.1111/cts.13576 · Cited by 70
Sex Differences in Culprit Plaque Characteristics Among Different Age Groups in Patients With Acute Coronary Syndromes
Seegers, L. M., Araki, M., Nakajima, A., Yonetsu, T., Minami, Y., Ako, J., Soeda, T., Kurihara, O., Higuma, T., Kimura, S., et al. (2022) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.121.011612 · Cited by 71
NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
Zhang, L., Ai, C., Bai, M., Niu, J., & Zhang, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810632 · Cited by 73
Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich–Containing Family, Pyrin Domain–Containing-3) Inflammasome in Cardiovascular Disorders
Wang, Z., Hu, W., Lu, C., Ma, Z., Jiang, S., Gu, C., Acuña-Castroviejo, D., & Yang, Y. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311916 · Cited by 72
Ox-LDL Causes Endothelial Cell Injury Through ASK1/NLRP3-Mediated Inflammasome Activation via Endoplasmic Reticulum Stress
Hang, L., Peng, Y., Xiang, R., Li, X., & Li, Z. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s231916 · Cited by 68
Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target
Hadri, K. E., Smith, R., Duplus, E., & Amri, C. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010077 · Cited by 71
Enhancing CAR Macrophage Efferocytosis Via Surface Engineered Lipid Nanoparticles Targeting LXR Signaling
Chuang, S. T., Stein, J. B., Nevins, S., Bektas, C. K., Choi, H. K., Ko, W., Jang, H., Ha, J., & Lee, K. (2024) · Advanced Materials · doi:10.1002/adma.202308377 · Cited by 69
Insight into the mechanisms regulating immune homeostasis in health and disease.
Sirisinha, S. (2011) · PubMed · Cited by 68
Network Analysis of Inflammatory Genes and Their Transcriptional Regulators in Coronary Artery Disease
Nair, J., Ghatge, M., Kakkar, V. V., & Shanker, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094328 · Cited by 68
Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis
Hakimi, M., Peters, A. S., Becker, A., Böckler, D., & Dihlmann, S. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.03.048 · Cited by 67
L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages
Yang, T., Chang, P., & Lu, S. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00509.2016 · Cited by 68
Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions
Yoon, M. C., Solania, A., Jiang, Z., Christy, M. P., Podvin, S., Mosier, C., Lietz, C. B., Ito, G., Gerwick, W. H., Wolan, D. W., et al. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00138 · Cited by 67
The shared role of cholesterol in neuronal and peripheral inflammation
Hansen, S. B., & Wang, H. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108486 · Cited by 69
Role of Genetic Alterations in the NLRP3 and CARD8 Genes in Health and Disease
Paramel, G. V., Sirsjö, A., & Fransén, K. (2015) · Mediators of Inflammation · doi:10.1155/2015/846782 · Cited by 66
Role of the Inflammasome in Myocardial Infarction
Takahashi, M. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.02.002 · Cited by 66
Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis
Pulanco, M. C., Cosman, J., Ho, M.-M., Huynh, J., Fing, K., Turcu, J., & Fraser, D. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601445 · Cited by 66
Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases
Damen, M. S. M. A., Popa, C. D., Netea, M. G., Dinarello, C. A., & Joosten, L. A. B. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.07.005 · Cited by 68
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Pavillard, L. E., Marín‐Aguilar, F., Bullón, P., & Cordero, M. D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.018 · Cited by 67

Authors: Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K.
Affiliations: Wihuri Research Institute (FI)
Finnish Institute of Occupational Health (FI)
Corresponding author: Rajamäki, Kristiina
ORCID: Rajamäki, Kristiina
Lappalainen, Jani
Öörni, Katariina
Matikainen, Sampsa
Kovanen, Petri T.
Eklund, Kari K.
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2010-07-23
Volume: 5
Issue: 7
Pages: e11765
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0011765
PMC: PMC2909263
OpenAlex: W2028545985
Semantic Scholar: fa6cd20e147dd066a3358c77aa3fc9b4dc9ff451
Cited by: 1,039
References: 60
Citations by year: 2026: 65 · 2025: 51 · 2024: 45 · 2023: 77 · 2022: 80 · 2021: 74 · 2020: 72 · 2019: 57 · 2018: 66 · 2017: 77 · 2016: 52 · 2015: 76 · 2014: 75 · 2013: 70 · 2012: 59
FWCI: 21.86
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: Jenny ja Antti Wihurin Rahasto
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: cholesterol crystals, NLRP3 inflammasome, macrophages, atherosclerosis, IL-1β secretion, caspase-1, lysosomal destabilization, cathepsin B, cholesterol esters, cholesterol metabolism, inflammation, monocytes
MeSH terms: NLR Family, Pyrin Domain-Containing 3 Protein, Carrier Proteins, Cathepsin B, Cells, Cultured, Cholesterol, Chromatography, Thin Layer, Cytoplasm, Humans, Inflammation, Lipopolysaccharides, Lysosomes, Macrophages, Monocytes, Phagocytosis, Potassium, Blotting, Western, Cytochalasin D, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Caspase 1, RNA, Small Interfering, Interleukin-1beta, Caspase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks